These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16553526)

  • 21. Suicidal thinking and behavior during treatment with sertraline in late-life depression.
    Nelson JC; Delucchi K; Schneider L
    Am J Geriatr Psychiatry; 2007 Jul; 15(7):573-80. PubMed ID: 17586782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.
    Stübner S; Grohmann R; Greil W; Zhang X; Müller-Oerlinghausen B; Bleich S; Rüther E; Möller HJ; Engel R; Falkai P; Toto S; Kasper S; Neyazi A
    Int J Neuropsychopharmacol; 2018 Sep; 21(9):814-821. PubMed ID: 29939264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone.
    Karayal ON; Anway SD; Batzar E; Vanderburg DG
    J Clin Psychiatry; 2011 Mar; 72(3):367-75. PubMed ID: 21450154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants and Suicidality.
    Brent DA
    Psychiatr Clin North Am; 2016 Sep; 39(3):503-12. PubMed ID: 27514302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reports of suicidality in clinical trials of montelukast.
    Philip G; Hustad C; Noonan G; Malice MP; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):691-6.e6. PubMed ID: 19815114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of adverse behavioral effects with pediatric use of antidepressants.
    Goodman WK; Murphy TK; Storch EA
    Psychopharmacology (Berl); 2007 Mar; 191(1):87-96. PubMed ID: 17180618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suicidality and other severe psychiatric events with duloxetine: Re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia.
    Hengartner MP; Plöderl M
    Int J Risk Saf Med; 2021; 32(3):209-218. PubMed ID: 34397423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.
    Hudson JI; Wohlreich MM; Kajdasz DK; Mallinckrodt CH; Watkin JG; Martynov OV
    Hum Psychopharmacol; 2005 Jul; 20(5):327-41. PubMed ID: 15912562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
    J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants and suicidal behavior in bipolar disorder.
    McElroy SL; Kotwal R; Kaneria R; Keck PE
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):596-617. PubMed ID: 17042833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pooled analysis of suicidality in double-blind, placebo-controlled studies of sertraline in adults.
    Vanderburg DG; Batzar E; Fogel I; Kremer CM
    J Clin Psychiatry; 2009 May; 70(5):674-83. PubMed ID: 19552866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs associated with more suicidal ideations are also associated with more suicide attempts.
    Robertson HT; Allison DB
    PLoS One; 2009 Oct; 4(10):e7312. PubMed ID: 19798416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant side effects in children and adolescents.
    Gualtieri CT; Johnson LG
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):147-57. PubMed ID: 16553535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.
    Khan A; Warner HA; Brown WA
    Arch Gen Psychiatry; 2000 Apr; 57(4):311-7. PubMed ID: 10768687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion.
    Wightman DS; Foster VJ; Krishen A; Richard NE; Modell JG
    Prim Care Companion J Clin Psychiatry; 2010; 12(5):. PubMed ID: 21274361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Yusuf-Peto method was not a robust method for meta-analyses of rare events data from antidepressant trials.
    Sharma T; Gøtzsche PC; Kuss O
    J Clin Epidemiol; 2017 Nov; 91():129-136. PubMed ID: 28802674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics of suicidal events.
    Brent D; Melhem N; Turecki G
    Pharmacogenomics; 2010 Jun; 11(6):793-807. PubMed ID: 20504254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressants and suicidality: A re-analysis of the re-analysis.
    Kaminski JA; Bschor T
    J Affect Disord; 2020 Apr; 266():95-99. PubMed ID: 32056952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.